Podcast
Questions and Answers
What is the generic name of Breo Ellipta?
What is the generic name of Breo Ellipta?
fluticasone furoate/vilanterol
What is the dosage of Breo Ellipta?
What is the dosage of Breo Ellipta?
DPI: 100 mcg fluticasone/25 mcg vilanterol and 200 mcg fluticasone/25 mcg vilanterol; inhalation; 1 inhalation daily, 24 hr duration
What classification does Breo Ellipta fall under?
What classification does Breo Ellipta fall under?
Corticosteroid/LABA Anticholinergic
What receptor sites does Breo Ellipta target?
What receptor sites does Breo Ellipta target?
Signup and view all the answers
What are the indications for using Breo Ellipta?
What are the indications for using Breo Ellipta?
Signup and view all the answers
What are the contraindications for Breo Ellipta?
What are the contraindications for Breo Ellipta?
Signup and view all the answers
What hazards are associated with Breo Ellipta?
What hazards are associated with Breo Ellipta?
Signup and view all the answers
What is the duration of action of Breo Ellipta?
What is the duration of action of Breo Ellipta?
Signup and view all the answers
What should a patient do after using corticosteroids?
What should a patient do after using corticosteroids?
Signup and view all the answers
What kind of inhaler is Breo Ellipta?
What kind of inhaler is Breo Ellipta?
Signup and view all the answers
Study Notes
Breo Ellipta Overview
- Generic name: Fluticasone furoate/vilanterol
- Formulation: Dry powder inhaler (DPI)
Dosage Information
- Available strengths: 100 mcg fluticasone/25 mcg vilanterol and 200 mcg fluticasone/25 mcg vilanterol
- Administration: 1 inhalation daily for 24-hour duration
Classification
- Type: Combination corticosteroid and long-acting beta-agonist (LABA)
- Mechanism: Anticholinergic properties
Receptor Interaction
- Acts on anti-inflammatory receptors and Beta-2 adrenergic receptors
Clinical Indications
- Indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in patients aged 18 years and older
Contraindications
- Not suitable for acute bronchospasm
- Long-term use of short-acting beta agonists (SABAs) and LABAs is not recommended
- Use the lowest effective dose; always rinse mouth post-inhalation
- Special caution for patients with existing cardiac issues and chronic lung diseases
Potential Hazards
- Risks include oropharyngeal fungal infections, dysphonia, cough, and bronchoconstriction
- Prolonged use can lead to HPA axis suppression and growth restriction in children
- Monitoring of pulse rate is advised due to cardiac effects linked to beta agonist activity
Duration of Action
- Provides relief for up to 24 hours
Post-Use Instructions
- Patients should rinse their mouths with water after using corticosteroids to prevent oral thrush
Inhaler Type
- Administered via a dry powder inhaler (DPI)
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge of the Breo Ellipta inhaler, including its generic name, dosage details, and classification. These flashcards provide essential information to enhance your understanding of this medication's properties and usage.
